News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,851 Results
Type
Article (41633)
Company Profile (268)
Press Release (687936)
Multimedia
Podcasts (87)
Webinars (20)
Section
Business (205654)
Career Advice (2134)
Deals (35798)
Drug Delivery (127)
Drug Development (81565)
Employer Resources (179)
FDA (16586)
Job Trends (15073)
News (348247)
Policy (32987)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2597)
Accelerated approval (43)
Adcomms (26)
Allergies (162)
Alliances (49809)
ALS (192)
Alzheimer's disease (1743)
Antibody-drug conjugate (ADC) (368)
Approvals (16903)
Artificial intelligence (598)
Autoimmune disease (222)
Automation (50)
Bankruptcy (364)
Best Places to Work (11721)
BIOSECURE Act (20)
Biosimilars (207)
Biotechnology (176)
Bladder cancer (178)
Brain cancer (64)
Breast cancer (687)
Cancer (5318)
Cardiovascular disease (450)
Career advice (1797)
Career pathing (40)
CAR-T (299)
CDC (54)
Celiac Disease (2)
Cell therapy (800)
Cervical cancer (41)
Clinical research (70303)
Collaboration (1902)
Company closure (4)
Compensation (1270)
Complete response letters (72)
COVID-19 (2729)
CRISPR (98)
C-suite (976)
Cystic fibrosis (148)
Data (7043)
Decentralized trials (3)
Denatured (26)
Depression (156)
Dermatology (57)
Diabetes (558)
Diagnostics (6848)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (293)
Drug pricing (203)
Drug shortages (32)
Duchenne muscular dystrophy (265)
Earnings (91341)
Editorial (60)
Employer branding (24)
Employer resources (157)
Events (118769)
Executive appointments (1033)
FDA (20010)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1611)
Gene editing (210)
Generative AI (51)
Gene therapy (652)
GLP-1 (1045)
Government (4725)
Grass and pollen (7)
Guidances (396)
Healthcare (19041)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (273)
Immuno-oncology (80)
Indications (157)
Infectious disease (3043)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (273)
Interviews (337)
IPO (16713)
IRA (50)
Job creations (3673)
Job search strategy (1501)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (558)
Leadership (35)
Legal (8028)
Liver cancer (98)
Longevity (28)
Lung cancer (715)
Lymphoma (407)
Machine learning (52)
Management (59)
Manufacturing (922)
MASH (177)
Medical device (13941)
Medtech (14019)
Mergers & acquisitions (20244)
Metabolic disorders (1437)
mRNA (173)
Multiple sclerosis (173)
NASH (18)
Neurodegenerative disease (383)
Neuropsychiatric disorders (99)
Neuroscience (3136)
Neurotech (1)
NextGen: Class of 2026 (6598)
Non-profit (4543)
Now hiring (73)
Obesity (683)
Opinion (281)
Ovarian cancer (185)
Pain (227)
Pancreatic cancer (254)
Parkinson's disease (337)
Partnered (34)
Patents (555)
Patient recruitment (589)
Peanut (60)
People (59468)
Pharmaceutical (59)
Pharmacy benefit managers (33)
Phase 1 (21902)
Phase 2 (30936)
Phase 3 (23075)
Pipeline (7109)
Policy (306)
Postmarket research (2578)
Preclinical (9280)
Press Release (64)
Prostate cancer (275)
Psychedelics (49)
Radiopharmaceuticals (302)
Rare diseases (999)
Real estate (6005)
Recruiting (74)
Regulatory (25131)
Reports (56)
Research institute (2412)
Resumes & cover letters (372)
Rett syndrome (32)
RNA editing (17)
RSV (87)
Schizophrenia (165)
Series A (267)
Series B (200)
Service/supplier (12)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (45)
Startups (3652)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (88)
The Weekly (59)
Vaccines (1059)
Venture capital (98)
Weight loss (439)
Women's health (110)
Worklife (20)
Date
Last 7 days (637)
Last 30 days (2427)
Last 365 days (29977)
2026 (8000)
2025 (30287)
2024 (35324)
2023 (40198)
2022 (51291)
2021 (55841)
2020 (54303)
2019 (46948)
2018 (35299)
2017 (32272)
2016 (31651)
2015 (37751)
2014 (31467)
2013 (26513)
2012 (28758)
2011 (29413)
2010 (27466)
Location
Africa (750)
Alabama (90)
Alaska (7)
Arizona (332)
Arkansas (13)
Asia (39776)
Australia (6489)
California (12253)
Canada (3512)
China (1227)
Colorado (522)
Connecticut (521)
Delaware (366)
Europe (85906)
Florida (1849)
Georgia (393)
Hawaii (3)
Idaho (63)
Illinois (962)
India (81)
Indiana (560)
Iowa (22)
Japan (486)
Kansas (131)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1482)
Massachusetts (8767)
Michigan (347)
Minnesota (683)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (136)
New Hampshire (83)
New Jersey (3282)
New Mexico (28)
New York (3238)
North Carolina (1559)
North Dakota (8)
Northern California (6058)
Ohio (367)
Oklahoma (22)
Oregon (41)
Pennsylvania (2482)
Puerto Rico (26)
Rhode Island (50)
South America (1141)
South Carolina (77)
South Dakota (1)
Southern California (4816)
Tennessee (199)
Texas (1930)
United States (43466)
Utah (367)
Vermont (1)
Virginia (291)
Washington D.C. (80)
Washington State (981)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
729,851 Results for "prestige brands inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
October 20, 2025
·
4 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
Press Releases
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
October 28, 2025
·
7 min read
Press Releases
Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™
January 9, 2026
·
4 min read
Press Releases
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
VINIA’s leadership position in the market validates its superior arterial dilation and blood flow performance as well as BioHarvest’s Botanical Synthesis platform technology
March 26, 2026
·
5 min read
Press Releases
Nextleaf Solutions Scales up CPG Brand Growth with an Enhanced National Commercial Platform
February 19, 2026
·
6 min read
Press Releases
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey’s Aquanil Brand for Sensitive Skin
March 18, 2026
·
4 min read
Press Releases
Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025
September 25, 2025
·
1 min read
Press Releases
Aires Enters Collaboration Agreement with Leading Wellness Expert Gary Brecka’s Brand, The Ultimate Human
February 2, 2026
·
6 min read
Press Releases
PharmaTher Introduces PatchPrint(TM) With Provisional Patent Filing and Commercialization Strategy for Microneedle Patches
Leveraging its PharmaPatch™ experience, the Company is introducing PatchPrint™ to support existing microneedle patch programs and expand into on-demand personalized patch solutions, including peptide patches, branded wellness patches, manufacturing systems and commercial partnerships.
March 26, 2026
·
9 min read
1 of 72,986
Next
